Table 3.

Patients’ associated medical problems 15 years after SG

	All patients* (n=48)	Non-conversion* (n=24)	Conversion* (n=24)
No associated medical problems (SG)	34/48 (70.8%)	19/24 (79.2%)	15/24 (62.5%)
No associated medical problems (15 years)	36/48 (75.0%)	19/24 (79.2%)	17/24 (70.8%)
Arterial hypertension (SG)	12/48 (25.0%)	8/24 (33.3%)	4/24 (16.7%)
Remission (15 years)	6/12 (50.0%)	3/8 (37.5%)	3/4 (75.0%)
New onset (15 years)	2/36 (5.6%)	1/16 (6.3%)	1/20 (5.0%)
Diabetes mellitus II (SG)	1/48 (2.1%)	1/24 (4.2%)	0
Remission (15 years)	0	0	0
New onset (15 years)	1/47 (2.1%)	1/23 (4.3%)	0
Hyperlipidemia (SG)	2/48 (4.2%)	1/24 (4.2%)	1/24 (4.2%)
Remission (15 years)	0	0	0
New onset (15 years)	1/46 (2.2%)	0	1/23 (4.3%)
Obstructive sleep apnea (SG)	1/48 (2.1%)	0	1/24 (4.2%)
Remission (15 years)	1/1 (100%)	0	1/1 (100%)
New onset (15 years)	0	0	0
Diseases of bones and joints (SG)	3/48 (6.3%)	1/24 (4.2%)	2/24 (8.3%)
Remission (15 years)	0	0	0
New onset (15 years)	2/45 (4.4%)	0	2/22 (9.0%)

*Deceased and acutely converted patients (n=5) were removed from this calculation

Abbreviations: SG sleeve gastrectomy